Statin Therapy for Patients with Cardiovascular Disease (SPC)

HEDIS Measure

Statin Therapy for Patients with Cardiovascular Disease (SPC)

Line of business: Commercial Medicaid Medicare

Data Collection Method: Administrative (Claims)

Measure Description

The percentage of males 21–75 years of age and females 40–75 years of age during the measurement year, who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) and met the following criteria.

The following rates are reported:

• Received Statin Therapy. Members who were dispensed at least one high-intensity or moderate-intensity statin medication during the measurement year.
• Statin Adherence 80%. Members who remained on a high-intensity or moderate- intensity statin medication for at least 80% of the treatment period.

Numerator Compliance

Received Statin Therapy - At least one dispensing event for a high-intensity or moderate-intensity statin medication during the measurement year.

Statin Adherence 80% - Members who achieved a PDC of at least 80% during the treatment period.

IPSD - Index prescription start date. The earliest prescription dispensing date for any statin medication of at leastmoderate intensity during the measurement year.

Treatment period - number of days beginning on the IPSD through the end of the measurement year.

PDC - Proportion of Days Covered. The number of days the member is covered by at least one statin medication prescription of appropriate intensity, divided by the number of days in the treatment period

Best Practices

• Educate on the importance of complying with statin therapy during every communication
• Simplify the medication regimen by using once-daily dosing, if possible
• Listen to members’ concerns and make them an active part of shared-decision making
• Routinely arrange the next appointment for consistent follow-up and monitoring

High And Moderate Intensity Statin Medications